Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Feb;71(2):767.
doi: 10.1002/hep.30981. Epub 2020 Jan 24.

Letter to the Editor: Impact of Nonalcoholic Steatohepatitis on Liver-Related Outcomes in Chronic Hepatitis B

Rui Huang  1 , Jian Wang  1 , Zhaoping Zhang  1 , Xiaomin Yan  1 , Chao Wu  1
Affiliations
Comment

Letter to the Editor: Impact of Nonalcoholic Steatohepatitis on Liver-Related Outcomes in Chronic Hepatitis B

Rui Huang et al. Hepatology. 2020 Feb.
No abstract available

PubMed Disclaimer

Comment in

  • Reply.
    Choi HSJ, Brouwer WP, Hansen BE, Janssen HLA, Patel K. Choi HSJ, et al. Hepatology. 2020 Feb;71(2):769. doi: 10.1002/hep.30980. Epub 2020 Jan 28. Hepatology. 2020. PMID: 31593309 No abstract available.

Comment on

References

    1. Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen BE, et al. Non-alcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B. Hepatology 2019 Jul 15. https://doi.org/10.1002/hep.30857. [Epub ahead of print]
    1. Bai H, Liu H, Chen X, Xu C, Dou X. Influence of age and HBeAg status on the correlation between HBV DNA and hepatic inflammation and fibrosis in chronic hepatitis B patients. Dig Dis Sci 2013;58:1355-1362.
    1. Choi J, Kim HJ, Lee J, Cho S, Ko MJ, Lim YS. Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B: a Korean nationwide cohort study. JAMA Oncol 2019;5:30-36.
    1. Lee TY, Hsu YC, Tseng HC, Yu SH, Lin JT, Wu MS, et al. Association of daily aspirin therapy with risk of hepatocellular carcinoma in patients with chronic hepatitis B. JAMA Intern Med 2019;179:633-640.
    1. Tsan YT, Lee CH, Wang JD, Chen PC. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol 2012;30:623-630.